miltefosine has been researched along with pa 824 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaser, A; Denny, WA; Franzblau, SG; Gupta, S; Launay, D; Ma, Z; Maes, L; Martin, D; O'Connor, PD; Thompson, AM; Wan, B; Wang, Y; Yardley, V | 1 |
| Braillard, S; Chatelain, E; Cooper, CB; Denny, WA; Franzblau, SG; Gupta, S; Launay, D; Ma, Z; Maes, L; Marshall, AJ; O'Connor, PD; Thompson, AM; Wan, B; Wang, Y; Yardley, V | 1 |
| Blaser, A; Braillard, S; Chatelain, E; Cooper, CB; Denny, WA; Franzblau, SG; Gupta, S; Launay, D; Ma, Z; Maes, L; Marshall, AJ; O'Connor, PD; Thompson, AM; Wan, B; Yardley, V | 1 |
3 other study(ies) available for miltefosine and pa 824
| Article | Year |
|---|---|
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; Cricetinae; Drug Repositioning; Female; High-Throughput Screening Assays; Hydrogen-Ion Concentration; Leishmania infantum; Leishmaniasis, Visceral; Mesocricetus; Mice; Mice, Inbred BALB C; Microsomes, Liver; Models, Molecular; Solubility; Structure-Activity Relationship | 2016 |
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; Cricetinae; Drug Discovery; Female; Humans; Leishmania donovani; Leishmania infantum; Leishmaniasis, Visceral; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxazines; Rats, Sprague-Dawley | 2017 |
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.
Topics: Animals; Antiparasitic Agents; Cell Membrane Permeability; Chagas Disease; Cricetinae; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; ERG1 Potassium Channel; Leishmania donovani; Leishmania infantum; Leishmaniasis, Visceral; Mesocricetus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2018 |